Advertisement

Topics

R3 Stem Cell Achieves Certification by the Better Business Bureau

03:00 EDT 7 Aug 2017 | PR Web

After five years of offering top stem cell therapy treatments nationwide to thousands of patients, R3 Stem Cell has achieved Better Business Bureau accreditation. The company places immense quality assurance on patient satisfaction along with the quality of service, which has contributed to the BBB accreditation.

Scottsdale, Arizona (PRWEB) August 07, 2017

After five years of offering top stem cell therapy treatments nationwide to thousands of patients, R3 Stem Cell has achieved Better Business Bureau accreditation. The company places immense quality assurance on patient satisfaction along with the quality of service, which has contributed to the BBB accreditation.

R3 Stem Cell's regenerative procedures have been used for all types of patient conditions such as degenerative arthritis, sports injuries, wound healing, tendonitis, systemic conditions and cosmetic procedures. Patients receive benefits the vast majority of the time, and no adverse events have been reported in thousands of cases.

Said CEO David Greene, "We put immense quality assurance on our amniotic stem cell products and the patient experience. Everything revolves around patient safety, quality service, first rate outcomes and satisfaction!"

The amniotic stem cell products utilized at R3 Stem Cell Centers of Excellence have no ethical issues. The products are obtained after scheduled c-sections by consenting donors and no embryonic cells are involved. R3 is now offering on demand webinars for prospective patients on its website along with having over 35 videos for education.

For top stem cell therapy nationwide, call R3 Stem Cell at (844) GET-STEM today!

For the original version on PRWeb visit: http://www.prweb.com/releases/2017/08/prweb14573531.htm

NEXT ARTICLE

More From BioPortfolio on "R3 Stem Cell Achieves Certification by the Better Business Bureau"

Quick Search
Advertisement
 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....